V
Vinod Pullarkat
Researcher at City of Hope National Medical Center
Publications - 280
Citations - 9132
Vinod Pullarkat is an academic researcher from City of Hope National Medical Center. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 37, co-authored 219 publications receiving 6536 citations. Previous affiliations of Vinod Pullarkat include University of Southern California & Biogen Idec.
Papers
More filters
Journal ArticleDOI
Improved Outcomes Using Tacrolimus/Sirolimus for graft Versus Host Disease prophylaxis with a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant for Myelofibrosis
David S. Snyder,Joycelynne Palmer,Karl Gaal,Anthony S. Stein,Vinod Pullarkat,N. Vora,Ryotaro Nakamura,Firoozeh Sahebi,Stephen J. Forman +8 more
TL;DR: A combination of tacrolimus(tacro)/sirolimus (siro) +/− methotrexate (MTX) for GVHD prophylaxis in a cohort of 14 consecutive pts with MF treated with RIC HCT at City of Hope in an effort to reduce TRM from GV HD and related complications.
Journal ArticleDOI
Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL)
Amrita Krishnan,Karen L. Chang,Henry C. Fung,Margaret R. O'Donnell,Ravi Bhatia,Ricardo Spielberger,Vinod Pullarkat,Anthony S. Stein,Neil Kogut,Mark Kirschbaum,E. Bolotin,C. Sarkodee-Adoo,Andrew Dagis,Nigel Cheng,Stephen J. Forman +14 more
TL;DR: Despite unfavorable cytogenetics in many patients, relapse rates are low following AsCT for BAL and comparable to pts undergoing ASCT for AML, according to a retrospective study of patients with BAL.
Journal ArticleDOI
Matched Unrelated Donor Hematopoietic Cell Transplantation Following Reduced-Intensity Conditioning for Treatment of Myelofibrosis.
David S. Snyder,Anthony S. Stein,Vinod Pullarkat,Firoozeh Sahebi,Sandra Cohen,Joycelynne Palmer,Nayan Vora,Ryotora Nakamura,Stephen J. Forman +8 more
TL;DR: It is demonstrated that MUD HCT utilizing PBSC can be an effective treatment for older pts with MF and reduced intensity conditioning (RIC) regimens followed by allogeneic HCT.
Journal ArticleDOI
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions
Ibrahim Aldoss,Michelle Afkhami,Dongyun Yang,Zhaohui Xu,Sally Mokhtari,Shilpa A Shahani,Hoda Pourhassan,Vaibhav Agrawal,Paul Koller,Shukaib Arslan,Vanina Tomasian,Monzr M. Al Malki,Andrew S. Artz,Amandeep Salhotra,Haris Ali,Ahmed Aribi,Karamjeet S. Sandhu,Brian Ball,Salman Otoukesh,I. Amanam,Pamela S. Becker,F. Stewart,Peter T. Curtin,Eileen P. Smith,Milhan Telatar,Anthony S. Stein,Guido Marcucci,Stephen J. Forman,Ryotaro Nakamura,Vinod Pullarkat +29 more
TL;DR: This paper conducted a single-center retrospective analysis of adult patients with relapsed/refractory (r/r) Ph-like ALL and fusions associated with PH-like who received novel salvage therapies.
Journal ArticleDOI
Post-transplant sinusoidal obstruction syndrome in adult patients with B-cell Acute Lymphoblastic Leukemia treated with pre-transplant Inotuzumab.
Vaibhav Agrawal,Hoda Pourhassan,Ni-Chun Tsai,Dat Ngo,Paul Koller,Monzr M. Al Malki,Amandeep Salhotra,Haris Ali,Ahmed Aribi,Karamjeet S. Sandhu,Shukaib Arslan,Brian Ball,Salman Otoukesh,I. Amanam,Andrew S. Artz,Dupinder Singh,Pamela S. Becker,F. Stewart,Eileen P. Smith,Peter T. Curtin,Anthony S. Stein,Guido Marcucci,Stephen J. Forman,Ryotaro Nakamura,Vinod Pullarkat,Ibrahim Aldoss +25 more
TL;DR: Sinusoidal obstruction syndrome (SOS) is a potentially life-threatening complication that can be observed after allogeneic hematopoietic cell transplantation (HCT) as discussed by the authors .